ebook Munafa Stock Market Course + Intraday & FNO calls  

       

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Dr. Reddy's Laboratories Ltd Complete list of announcements declared & dividend announcements by Dr. Reddy's Laboratories Ltd RDY

Dr. Reddy's Laboratories Ltd RDY listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Dr. Reddy's Laboratories Ltd RDY

Dr Reddy's ties up with Gilead to manufacture, commercialise HIV drug
Dr Reddy's Laboratories on Wednesday said it has tied up with Gilead Sciences for the manufacture and commercialisation of the HIV drug Lenacapavir in India and 120 other countries. The company has entered into a royalty-free non-exclusive voluntary licens
Announcement as on 02 October 2024

Dr Reddy's enters voluntary licensing deal with Gilead for long-acting HIV drug
Dr. Reddy’s has partnered with Gilead Sciences to manufacture and market the HIV drug Lenacapavir in India and 120 other countries. The agreement includes developing Lenacapavir for both treatment and potential prevention of HIV. This collaboration aims
Announcement as on 02 October 2024

Dr Reddy's Laboratories completes acquisition of Haleon's NRT portfolio
Dr Reddy's Laboratories on Monday said its Switzerland-based subsidiary has completed the acquisition of Haleon plc's global portfolio of consumer healthcare brands, outside of the US, in the Nicotine Replacement Therapy (NRT) category. Dr Reddy's Laborato
Announcement as on 30 September 2024

Dr Reddys acquires Haleon plc brands in NRT category
As part of this acquisition, Northstar Switzerland along with its wholly owned subsidiaries North Star OpCo Limited (United Kingdom) and North Star Sweden AB (Sweden) are now wholly-owned step-down subsidiaries of the Company with effect from 30 September
Announcement as on 30 September 2024

Dr Reddy's completes acquisition of Haleon's global NRT portfolio
DRL's Swiss subsidiary completed the acquisition through the purchase of shares of Northstar Switzerland SARL, a Haleon group company
Announcement as on 30 September 2024

Announcements by Dr. Reddy's Laboratories Ltd first page | Next page | Prev page |

RDY Dr. Reddy's Laboratories Ltd current price & indicator signals

Moving Averages for Dr. Reddy's Laboratories Ltd

  • 5Day Average: 12.14
  • 12Day Average: 11.96
  • 20Day Average: 12.08
  • 50Day Average: 13.09
  • 100Day Average: 13.25
  • 150Day Average: 13.49
  • 200Day Average: 13.6

RDY Indicators & signals

Indicator MACD (12,26,9)

12.11, 12.42, -0.41
Indicator MACD is in negative zone

Indicator ADX (14)

30, 21.88, 40.63
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 48
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of RDY Dr. Reddy's Laboratories Ltd are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
10 Mon Aug 2026 12.15 11.58 to 12.29 -0.57% 0.69 times
07 Fri Aug 2026 12.22 12.12 to 12.26 0.91% 0.9 times
06 Thu Aug 2026 12.11 12.05 to 12.22 -0.25% 0.9 times
05 Wed Aug 2026 12.14 12.13 to 12.24 0.33% 0.89 times
04 Tue Aug 2026 12.10 11.97 to 12.21 0.25% 0.72 times
03 Mon Aug 2026 12.07 11.95 to 12.14 1.86% 1.23 times
31 Fri Jul 2026 11.85 11.72 to 11.86 0.17% 1.06 times
30 Thu Jul 2026 11.83 11.75 to 11.87 0.6% 0.74 times
29 Wed Jul 2026 11.76 11.75 to 11.87 0.26% 0.82 times
28 Tue Jul 2026 11.73 11.60 to 11.89 -0.34% 1.46 times
27 Mon Jul 2026 11.77 11.70 to 11.88 -0.17% 1.27 times
24 Fri Jul 2026 11.79 11.68 to 11.98 0% 1.14 times

Videos related to: RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

 

Back to top